Sponsor:
Vanderbilt University Medical Center
Code:
NCT07189936
Conditions
Post-Acute COVID-19 Syndrome
Postural Tachycardia Syndrome (POTS)
SARS CoV 2 Infection
Long COVID19
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
To Measure levels of circulating monocyte/ T cell doublets at Baseline
To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment
To measure levels of circulating monocyte/ T cell doublets after 28 days of Placebo treatment
To Measure Splanchnic venous capacitance after 28 days of Treatment with 2HOBA
To Measure Splanchnic venous capacitance after 28 days of Treatment with Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-01. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2026-01-22.